Do Ads Noting A Drug’s ‘Targeted’ Mechanism Of Action Impact Perceptions Of the Product?

US FDA will study how presentations of a fictitious cancer drug’s targeted mechanism of action affect consumer and provider interest in the drug and their understanding of its benefits and risks. Another study will assess how consumers and primary care physicians interpret Rx drug names.

targeted medicine (Alamy) — US FDA to study targeted mechanism of action claims in prescription drug promotions • Source: Alamy

The US Food and Drug Administration’s Office of Prescription Drug Promotion is honing in on another aspect of Rx drug promotions: presentations about a product’s “targeted mechanism of action.”

OPDP announced the proposed study, “Targeted Mechanism of Action Presentations in Prescription Drug Promotion,” in a Federal Register notice...